Terminalia triptera
Terminalia triptera · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Terminalia triptera is a versatile plant species that has garnered significant interest within the field of ethnobotany. While many studies focus on its structural properties, its potential medicinal applications are increasingly being explored. Specifically, researchers are investigating how its bioactive compounds might influence metabolic processes in individuals with Type 2 Diabetes. Understanding these chemical properties could provide valuable insights into natural approaches for managing blood glucose levels. As scientific interest grows, this plant represents a promising subject for further pharmacological investigation.
- Synonyms
- Terminalia Tripteroides · Terminalia Hainanensis · 3 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Synonyms
Terminalia triptera is a taxonomically complex species that is associated with several important botanical synonyms. It is recognized in various scientific records as Terminalia hainanensis and Terminalia nigrovenulosa. The classification also extends to the specific variety known as Terminalia nigrovenulosa var. gracilior. Furthermore, researchers have historically linked this plant to the names Terminalia obliqua and Terminalia tripteroides. Understanding these shifting nomenclature relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia triptera is a fascinating member of the kingdom Plantae. This botanical specimen belongs to the class Equisetopsida and is categorized under the order Myrtales. Within this structural hierarchy, it is specifically classified under the family Combretaceae. Furthermore, it is a distinct species found within the genus Terminalia. Understanding these biological relationships provides essential insight into the plant's evolutionary lineage.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia triptera exhibits a broad geographical range that spans across various climates in Asia. In temperate regions, the species is specifically found within China, particularly on the island of Hainan. Its tropical distribution is equally extensive, stretching throughout the Indo-China peninsula. This includes significant populations located in Cambodia, Laos, Myanmar, and Thailand. Consequently, the plant thrives in diverse ecological niches ranging from temperate islands to lush tropical landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia triptera is a self-supporting plant that takes the form of a sturdy tree. Depending on its specific environmental conditions, this species can reach a maximum height of 10 meters. However, under optimal growth circumstances, it may extend further to reach a height of up to 20 meters. This versatile growth pattern allows the tree to establish a significant presence within its native habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Terminalia triptera demonstrates significant medicinal potential through its ability to treat type 2 diabetes. Research indicates that methanol extracts from the trunk bark and leaves of this plant provide efficient mammalian α-glucosidase inhibition. Specifically, the plant's bioactive compounds, such as (-)-epicatechin and eschweilenol C, act as potent inhibitors of the α-glucosidase enzyme. These isolated compounds exhibit anti-diabetic drug properties and show high effectiveness compared to the commercial drug acarbose. Consequently, the plant serves as a promising natural source for developing new treatments for type 2 diabetes management.